Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Nasacort AQ*


Contraindicated
Teratogenic in animals

Contraindicated
Nasacort AQ* :
Type Medicine Non Marketed
Originator B
Agent Mersaco
Distributor Mersaco
Laboratory Sanofi
Responsible Party Rhone Poulenc Rorer Puerto Rico Inc Distributeur: Rhone Poulenc Rorer Pharmaceutical Inc
Origin U.S.A.
Manufacturer Rhone Poulenc Rorer Puerto Rico
Origin U.S.A.
ATC R01AD11

Your comment will appear shortly after approval

Nasacort AQ* :

Revision Date : 29/062016


Effect Frequency
Blood cortisol decreased Not known
Bronchitis Common
Cataract Not known
Cough Common
Dizziness Not known
Dry mucous membranes Not known
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Not known
Dyspepsia Common
Dyspnoea (dyspnea) Not known
Epistaxis (Nasal bleeding) Common
Face oedema Not known
Fatigue Not known
Flu Syndrome Common
Glaucoma Not known
Headache Common
Hypersensitivity syndrome Not known
Insomnia Not known
Intraocular pressure increased Not known
Nasal congestion Not known
Nasal irritation Not known
Nasal septum perforation Rare
Nausea Not known
Parosmia Not known
Pharyngitis Common
Pruritus Not known
Rhinitis Common
Skin rash Not known
Sneezing Not known
Tooth disorder Common
Urticaria Not known

Different Units By MoH Code

Revision Date : 01/10/2011

Revision Date : 26/09/2013

Nasacort AQ* Nasacort AQ* Nasacort AQ* Nasacort AQ* Nasacort AQ* Nasacort AQ*

Nasacort AQ*  MoH 3007 :
Form Nasal spray, suspension
Packaging Bottle (HDPE) (high density polyethylene)
Package Size 20ml (120 doses)
Strength 55µg
NSSF ✘
Quarantine ✘
Reg. Number 78984/98
Submission date 01/01/1998
Registration Year 1998
Archived Date 2014


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info